Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 148,476 $ 187,288
Short-term restricted cash 993 1,051
Accounts receivable, net 47,930 170,619
Inventory 96,063 99,908
Prepaid expenses and other current assets 34,798 29,159
Total current assets 328,260 488,025
Long-term restricted cash 23 17
Property and equipment, net 63,493 66,431
Leased right-of-use assets 22,549 31,264
Intangible assets, net 58,031 73,630
Goodwill 318,588 318,588
Deferred tax assets 82,552 69,493
Other long-term assets 21,807 32,809
Total assets 895,303 1,080,257
Current liabilities:    
Accounts payable 30,628 21,551
Accrued price protection liability 44,472 71,684
Accrued expenses and other current liabilities 71,197 98,468
Accrued compensation 22,300 30,426
Total current liabilities 168,597 222,129
Long-term lease liabilities 19,433 26,243
Long-term debt 122,840 122,375
Other long-term liabilities 27,561 23,245
Total liabilities 338,431 393,992
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 84,362 shares issued and outstanding at September 30, 2024 and 81,818 shares issued and outstanding December 31, 2023 8 8
Additional paid-in capital 866,603 808,575
Accumulated other comprehensive loss (3,852) (3,791)
Accumulated deficit (305,887) (118,527)
Total stockholders’ equity 556,872 686,265
Total liabilities and stockholders’ equity $ 895,303 $ 1,080,257